[Lenalidomide; adverse effects and commercialisation]

Farm Hosp. 2008 Nov-Dec;32(6):358-60. doi: 10.1016/s1130-6343(08)76285-8.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Commerce
  • Female
  • Humans
  • Lenalidomide
  • Male
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide